Oxford Biomedica plc (OXBDF)

Market Cap	408.88M
Revenue (ttm)	161.24M
Net Income (ttm)	-54.07M
Shares Out	n/a
EPS (ttm)	-0.52
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,000
Average Volume	12,796
Open	3.927
Previous Close	n/a
Day's Range	3.927 - 3.927
52-Week Range	2.090 - 5.000
Beta	0.96
RSI	43.91
Earnings Date	Jun 23, 2025

About Oxford Biomedica

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its LentiVector platform technology is a lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems. The company operates in two segments, Platform and Product. The Platform segment engages in bioprocessing and process development activities for third parties. The Product segment is involved in the research and de...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1996
• Employees: 850
• Stock Exchange: OTCMKTS
• Ticker Symbol: OXBDF

Financial Performance

In 2024, Oxford Biomedica's revenue was 128.80 million, an increase of 43.84% compared to the previous year's 89.54 million. Losses were -43.19 million, -72.58% less than in 2023.

Financial numbers in GBP